Quality of life in chronic NSAID users: A comparison of the effect of omeprazole and misoprostol

Scandinavian Journal of Rheumatology

Volumn 30, Issue 6, 2001, Pages 328-334

  Yeomans, N ^a   Wilson, I ^a   Langstrom G ^a   Hawkey, C ^a   Naesdal, J ^a   Walan, A ^a   Wiklund, I ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Arthritis; Clinical trial; Gastrointestinal symptoms; Heartburn; Misoprostol; NSAIDs; Omeprazole; Quality of life

Indexed keywords

MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PLACEBO;

ADULT; AGED; ARTICLE; DRUG EFFICACY; DYSPEPSIA; FEMALE; GASTRODUODENAL ULCER; HEALING; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RHEUMATOID ARTHRITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; COHORT STUDIES; FEMALE; HUMANS; LONG-TERM CARE; MALE; MIDDLE AGED; MISOPROSTOL; NORWAY; OMEPRAZOLE; PROBABILITY; QUALITY OF LIFE; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; STOMACH ULCER; STRESS, PSYCHOLOGICAL;

EID: 0035658894     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/030097401317148516     Document Type: Article

References (38)

1. Arthritis prevalence and activity limitations - United States, 1990
2. The Nottingham health profile as a measure of disease activity and outcome in rheumatoid arthritis
3. A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial
4. Outcome measures, pooled index and quality of life instruments in rheumatoid arthritis
5. Measuring outcome in rheumatoid arthritis - Which measures are suitable for routine clinical use?
6. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinfiammatory drugs
7. The Psychological General Well-Being (PGWB) index
8. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer
9. Reliability of a population survey tool for measuring perceived health problems: A study of patients with osteoarthrosis
10. A quantitative approach to perceived health status: A validation study
11. Joint pain and quality of life; Results from a randomised trial
12. Perceived health: Age and sex norms in a community
13. Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease
14. Views of patients and physicians regarding the importance of various aspects of arthritis treatment. Correlations with health status and patient satisfaction
15. Quality of life assessment during six months of NSAID treatment
16. Medico-economic analysis of diacerein with or without standard therapy in the treatment of osteoarthritis
17. Change and status in quality of life in patients with rheumatoid arthritis
18. Health status in chronic disease: A comparative study of rheumatoid arthritis
19. Functional status and well-being of patients with chronic conditions. Results from the medical outcomes study
20. Cross-sectional assessment and subgroup comparison of functional disability in patients with rheumatoid arthritis in a Swedish health-care district
21. Improvement in quality of life and exercise capacity after coronary bypass surgery
22. Gastrointestinal symptoms and health related quality of life in patients with arthritis
23. Patient preferences for nonsteroidal antiinflammatory drug related gastrointestinal complications and their prophylaxis
24. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs
25. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic Multicentre Study
26. Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users
27. Quality of life in patients with heartburn but without esophagitis: Effects of treatment with omeprazole
28. Quality of life during acute and intermittent treatment of gastroesophageal reflux disease with omeprazole compared with ranitidine. Results from a multi-center clinical trial
29. Omeprazole produces a greater improvement in quality of life than placebo, antacid-alginate, ranitidine, cimetidine or cisapride in patients with gastro-oesophageal reflux disease
30. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: A prospective, double-blind, multi-center study
31. A cost-utility analysis of misoprostol prophylaxis for rheumatoid arthritis patients receiving nonsteroidal antiinflammatory drugs
32. Lohnt sich misoprostol-prophylaxe der NSAR-induzierten gastrointestinalen komplikationen?
33. Healthcare utilization associated with dyspepsia in patients with arthritis
34. Quality of life on antihypertensive drug therapy: Scientific end-point or marketing exercise?
35. An economic evaluation of omeprazole compared to misoprostol for the acute treatment and prevention of nonsteroidal anti inflammatory drugs (NSAIDs) associated gastroduodenal ulcers, erosions and symptoms